Hydrochloorthiazide Sandoz (Hydrochlorothiazide)

Hydrochloorthiazide Sandoz is indicated for the oral treatment of conditions where reduction of excess fluid and lowering of blood pressure are required. It is commonly prescribed as part of a comprehensive management plan for cardiovascular and renal conditions.

• Hypertension (high blood pressure)
• Edema associated with congestive heart failure
• Edema due to renal or hepatic disease
• Prevention of calcium kidney stones
• Management of fluid overload in cirrhosis

• Hydrochlorothiazide acts on the distal convoluted tubule of the nephron, where it blocks the Na⁺‑Cl⁻ symporter. By inhibiting sodium and chloride reabsorption, the drug increases urinary excretion of sodium, chloride, and water, leading to a reduction in extracellular fluid volume. The consequent decrease in plasma volume lowers cardiac output and peripheral resistance, contributing to a modest reduction in systemic blood pressure.

Like other thiazide diuretics, Hydrochloorthiazide Sandoz may cause a range of adverse reactions, most of which are mild and reversible, while a few can be serious and require medical attention.

Common

• Increased urination and mild dehydration
• Electrolyte disturbances such as low potassium or sodium
• Dizziness or light‑headedness, especially on standing
• Elevated blood glucose levels in susceptible individuals

Serious

• Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia)
• Acute kidney injury or worsening renal function
• Allergic reactions including rash, itching, or angioedema
• Significant drop in blood pressure (hypotension)

Before initiating Hydrochloorthiazide Sandoz, clinicians should evaluate patient history and laboratory values to minimize risk of complications.

• Assess renal function and avoid use in severe impairment
• Monitor serum electrolytes, especially potassium and sodium, during therapy
• Use cautiously in patients with diabetes or gout
• Avoid in individuals with known hypersensitivity to thiazide diuretics
• Consider dose adjustment in elderly patients due to increased sensitivity
• Review concomitant medications that may affect fluid and electrolyte balance

Hydrochloorthiazide Sandoz can interact with several drugs, altering its efficacy or increasing the risk of adverse effects.

Avoid

• Lithium, because thiazides can raise lithium levels and toxicity risk
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may reduce diuretic effectiveness
• Cyclosporine or other nephrotoxic agents that can worsen renal function

Use with caution

• ACE inhibitors, ARBs, or beta‑blockers, which may enhance blood‑pressure lowering
• Antidiabetic agents, as thiazides may impair glucose control
• Anticoagulants, where electrolyte shifts could affect clotting